美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Electra Therapeutics INC

13.25

-1.7500-11.67%

盤後：13.520.2700+2.04%19:59 EDT

成交量：512.43萬

成交額：7,457.47萬

市值：8.10億

市盈率：- -

高：15.50

開：15.00

低：13.25

收：15.00

52周最高：15.50

52周最低：13.25

股本：6,110.03萬

流通股本：2,166.67萬

量比：- -

換手率：23.65%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

隨着生物技術行業勢頭持續，Retension Pharmaceuticals和TRex Bio相繼提交美國IPO申請

免疫學藥物研發公司Electra(ETRA.US)IPO定價15美元募資3.5億今晚登陸納斯達克

生物科技公司Electra Therapeutics(ETRA.US)IPO定價14-16美元/股擬籌資3.25億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/ETRA"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ETRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETRA\",,,,,undefined,":{"symbol":"ETRA","market":"US","secType":"STK","nameCN":"Electra Therapeutics INC","latestPrice":13.25,"timestamp":1789761600000,"preClose":15,"halted":0,"volume":5124319,"hourTrading":{"tag":"盘后","latestPrice":13.52,"preClose":13.25,"latestTime":"19:59 EDT","volume":17079,"amount":234585.3427,"timestamp":1789775990519,"change":0.27,"changeRate":0.020377,"amplitude":0.037736},"delay":0,"changeRate":-0.11666666666666667,"floatShares":21666667,"shares":61100300,"eps":0,"marketStatus":"已收盤","change":-1.75,"latestTime":"09-18 16:00:00 EDT","open":15,"high":15.5,"low":13.25,"amount":74574706.341624,"amplitude":0.15,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":5,"adr":0,"listingDate":1789704000000,"exchange":"NASDAQ","adjPreClose":15,"postHourTrading":{"tag":"盘后","latestPrice":13.52,"preClose":13.25,"latestTime":"19:59 EDT","volume":17079,"amount":234585.3427,"timestamp":1789775990519,"change":0.27,"changeRate":0.020377,"amplitude":0.037736},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETRA\",,,,,undefined,":{"symbol":"ETRA","floatShares":21666667,"roa":"--","roe":"--","lyrEps":0,"shares":61100300,"dividePrice":0,"high":15.5,"amplitude":0.15,"preClose":15,"low":13.25,"week52Low":13.25,"pbRate":"--","week52High":15.5,"institutionHeld":0,"latestPrice":13.25,"eps":0,"divideRate":0,"volume":5124319,"delay":0,"ttmEps":0,"open":15,"prevYearClose":15,"prevWeekClose":15,"prevMonthClose":15,"prevQuarterClose":15,"fiveDayClose":15,"twentyDayClose":15,"sixtyDayClose":15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ETRA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ETRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ETRA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ETRA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668597668","title":"隨着生物技術行業勢頭持續，Retension Pharmaceuticals和TRex Bio相繼提交美國IPO申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2668597668","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668597668?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 06:35","pubTimestamp":1789770948,"startTime":"0","endTime":"0","summary":"更新版 1-随着生物技术行业势头持续，Retension Pharmaceuticals和TRex Bio相继提交美国IPO申请在第4、6-7段中补充了分析师评论路透9月18日-药物开发商Retension Pharmaceuticals和TRex Bio于上周五提交了在美国进行首次公开募股的申请文件，进一步充实了今年秋季IPO窗口期的生物技术项目储备。肯尼迪表示，鉴于Electra股价的下跌，生物科技公司的IPO将面临更严格的审查。Leerink Partners、古根海姆证券、奥本海默和Titan Partners是Retension此次发行的承销商。Retension和TRex将分别以股票代码“RTSN”和“TRXB”在纳斯达克上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4S45A1QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LLYZ","LU2089984988.USD","TREX","LU1061106388.HKD","LU0820562030.AUD","IE00BK4W5L77.USD","LU0096364046.USD","FHLC","GB00BDT5M118.USD","LU0354030438.USD","XLV","LU2236285917.USD","LU2237443895.HKD","LU2106854487.HKD","BK4086","LU1267930730.SGD","LU1023059063.AUD","LU2089284900.SGD","IE00BFSS8Q28.SGD","LU0266013472.USD","LU2168564065.EUR","LU0203201768.USD","SGXZ57979304.SGD","LU0385154629.USD","LU1057294990.SGD","LU2471134952.CNY","LU1868836757.USD","LU0122379950.USD","LU0114720955.EUR","LU0823416689.USD","PPH","LU1804176565.USD","IE00BN29S564.USD","LU0316494557.USD","LU2491050154.USD","BK4599","IE0001KFT4U8.USD","LU0109391861.USD","LU2168564495.EUR","ELIL","CURE","LU2896262040.SGD","CANC","LU2468319806.SGD","LU2211815571.USD","LU2361044865.SGD","IE00B2B36J28.USD","SGXZ51526630.SGD","IE00B4R5TH58.HKD","LU0640476718.USD","LU0354030511.USD","LU0320765992.SGD","LU1989771016.USD","LU0889565916.HKD","VHT","SG9999001176.SGD","IE00BJLML261.HKD","HRTS","LU2357305700.SGD","IE00B1BXHZ80.USD","LU0238689110.USD","IE00BFSS7M15.SGD","IXJ","LU0820561909.HKD","SGXZ99366536.SGD","LU2471134879.HKD","LU2491050071.SGD","LU2237438978.USD","LU2237443549.SGD","LU1323610961.USD","LU2602419157.SGD","LU0198837287.USD","IHE","IE00BK4W5M84.HKD","LU0106261372.USD","LU1868836914.USD","LU1988902786.USD","MHIP","LLYX","LU2089283258.USD","LU1868837300.USD","MEDX","LU0320765059.SGD","SG9999018865.SGD","TMED","LU2063271972.USD","BK4533","IE00B4JS1V06.HKD","LU0882574139.USD","LU0417517546.SGD","SG9999018857.SGD","SGXZ81514606.USD","LU1551013425.SGD","BK4588","LU0823434740.USD","LU0964807845.USD","SG9999017495.SGD","LU1280957306.USD","SGXZ31699556.SGD","LU0787776722.HKD","IE00BJJMRZ35.SGD","LU1366192091.USD","LU2417539215.USD","BK4516","LU2265009873.SGD","LU2461242641.AUD","LU2491049909.HKD","LU0689472784.USD","LU0006306889.USD","OZEM","SG9999015978.USD","SG9999014880.SGD","LU0471298777.SGD","LU2361045086.USD","IE00B775H168.HKD","LU2028103732.USD","LU2237443978.SGD","LU2756315318.SGD","LU1093756325.SGD","SG9999015945.SGD","SG9999015986.USD","LU2023250330.USD","LU2087625088.SGD","LU2361044949.HKD","LU1064131342.USD","IE00B7KXQ091.USD","LU2456880835.USD","LU2023250504.SGD","SG9999013999.USD","LU2360106947.USD","BK4007","LU1979441026.SGD","LU2746668461.USD","SG9999001176.USD","LU2213496289.HKD","LU2552382215.SGD","LU1035775433.USD","LU1623119135.USD","BK4581","LU2168563687.JPY","TRUH","THNR","LU2237443382.USD","LU2750360641.GBP","LU2462591350.SGD","SG9999015952.SGD","LU1720051017.SGD","LLII","LU0158827781.USD","SG9999014898.SGD","LU0094547139.USD","LU0820561818.USD","LU0256863902.USD","LU1814569148.SGD","LU2108987350.USD","LU2111349929.HKD","ETRA","RXL","IE0004445239.USD","LU1551013342.USD","LU0353189763.USD","LU2750360997.AUD","LU0234572021.USD","LU2112291526.USD","LU2756315664.SGD","LU0823434583.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2552382132.HKD","IE00BFTCPJ56.SGD","IE00BJJMRX11.SGD","LU0058720904.USD","LU2471134796.USD","ILDR","LU1712237335.SGD","LU1069344957.HKD","LU0432979614.USD","LU0079474960.USD","LU0471298694.HKD","IYH","LU0097036916.USD","LU0109394709.USD","LU1868837136.USD","LU0345770308.USD","ELIS","LU1691799644.USD","IE00B1XK9C88.USD","LU0158827948.USD","LU0174119429.USD","WDNA","LU1917777945.USD","LU2324357040.USD","PJP","LU0203202063.USD","IE0005OL40V9.USD","LU1145028129.USD","BK4585","LU0456855351.SGD","LU1629891620.HKD","LU1720051108.HKD","IE00BKDWB100.SGD","JDOC","LU2237443465.HKD","LU0466842654.USD","IE0004445015.USD","AGNG","LU1548497426.USD","LU1983299246.USD","LU2168564222.USD","LU2746668974.SGD","LU0225283273.USD","SG9999014906.USD","LU0133085943.USD","LU1093756168.USD","SG9999014914.USD","LU1232071149.USD","LU0061475181.USD","LU2462157665.USD","LU2264538146.SGD","LU2271345857.HKD","FTXH","LU2471134523.USD","LLY","GDOC","MEDI","LU0882574055.USD","LU2552382058.USD","LU0683600562.USD","LU0323591593.USD","LU1127390331.HKD","LU2023251221.USD","LU0786609619.USD","IE00BKPKM429.USD","LU0708995401.HKD","LU0256863811.USD","LU2237443622.USD","BK4534","LU0353189680.USD","LU0289739699.SGD","LU1291159041.SGD","LU1868836591.USD","LU0345770993.USD","LU2168564149.EUR","LU0943347566.SGD","LU0672654240.SGD","IE00BJJMRY28.SGD","LU1974910355.USD","LU0210536198.USD","IE00BWXC8680.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668094871","title":"免疫學藥物研發公司Electra(ETRA.US)IPO定價15美元募資3.5億 今晚登陸納斯達克","url":"https://stock-news.laohu8.com/highlight/detail?id=2668094871","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668094871?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 14:56","pubTimestamp":1789714618,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段免疫学药物开发公司Electra Therapeutics Inc.通过扩大规模的美国首次公开募股募集了3.5亿美元，发行价定在推介区间的中点。Electra的主要候选药物旨在治疗继发性噬血细胞性淋巴组织细胞增生症，这是一种严重的免疫系统过度反应。本次上市恰逢药企IPO行情火热。根据文件，Electra于10月完成了约1.827亿美元的C轮融资，由法国制药商赛诺菲旗下部门、OrbiMed和Redmile领投;截至今年6月30日，公司持有9770万美元现金及现金等价物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667612838","title":"生物科技公司Electra Therapeutics(ETRA.US)IPO定價14-16美元/股 擬籌資3.25億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667612838","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667612838?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 15:18","pubTimestamp":1789456715,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于开发靶向SIRP抗体、用于免疫疾病和癌症治疗的II/III期的生物科技公司Electra Therapeutics周一公布了首次公开募股的发行条款。Electra Therapeutics正在开发一类精准药物，靶向特定免疫细胞群体上表达的信号调节蛋白。Electra Therapeutics欲借今年生物科技板块IPO强劲表现的东风，为其处于临床阶段的免疫介导疾病和癌症药物管线筹集资金。汇编数据显示，今年美国生物科技与制药公司的IPO累计募资额已达68亿美元，平均加权回报率接近70%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","BK4581","BK4539","LENZ","UUP","IEIH","BK4585","HBImain","MEDX","UDN","BK4588","BK4007","BK4139","SYNB","ETRA","IBBJ","XBI","AGNG","159837","GDOC","LNGR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ETRA\",params:#limit:6,delay:false,,,undefined,":[]}}